European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 18 September 2026 - 16:00

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 18 September 2026 - 15:38

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 18 September 2026 - 15:12

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 8, Status: Authorised

Quarterly System Demo - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 September 2026, 09:00 (CEST) to 17 September 2026, 11:30 (CEST)

Submitted by Anonymous (not verified) on 18 September 2026 - 14:59

Quarterly System Demo - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 September 2026, 09:00 (CEST) to 17 September 2026, 11:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More